1. Home
  2. > Pharmaceutical
  3. > Therapy Market Trends
Endometriosis Therapeutics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

Endometriosis Therapeutics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

  • November 2022
  • 111 pages
  • ID: 6362620
  • Format: PDF
  • TechSci Research


Table of Contents

Endometriosis Therapeutics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Endometriosis Type (Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis Therapeutics), By Diagnostic Method (Ultrasound, Pelvic Examination, Laparoscopy, Magnetic Resonance Imaging, And Others), By Treatment Method (Hormonal Therapy, And Pain Management), By Drug Category (Oral Contraceptives, Progestins, NSAIDs, GnRH Analogues, And Others), By Diagnostics Type (Pure Medical Imaging, And General Laboratory Use), By Distribution Channel ( Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By End-User, (Hospitals & Clinics, Ambulatory Care Center, And Others), By Company, By Region

The global endometriosis therapeutics market is expected to increase appreciably through 2027.Endometriosis is a disorder characterized by the tissues like the covering of the uterus growing on the outer part of the uterus.

It is a type of chronic disease led to serve life-impacting pains during periods, sexual intercourse, urination, chronic pelvic pain, abdominal bloating, nausea, and fatigue.Sometimes extreme levels of these disorders can result in depression, anxiety, and infertility.

Across the globe, various initiatives are going to make people, majorly women, aware of the problem; there are many off-label practices due to lack of information. In developing countries, the cost of therapy is creating restrain in growth.
According to WHO, almost 10% of reproductive-age women will be affected by this syndrome or disease globally in 2021.Different government organizations and NGOs are running global campaigns to create Awareness.

Launching new advanced products and therapies, Awareness about continuous improvement in patients, and improvement in non-invasive diagnostic methods are one of the major factors responsible for the market. Thus, we can expect a rise in growth and demand in the market share of Endometriosis therapeutics in 2027.
Growing Awareness About the Disease and Treatment in Society
The increasing pervasiveness of gynecological and chronic diseases, an increasing number of people suffering from endometriosis, ongoing R&D activities for advanced endometriosis treatment, and rising demand for hormonal therapies & novel drugs are factors responsible for the growth of the Endometriosis Therapeutics Market.As the population increases, the demand for medical treatment and equipment is increasing in various parts of the world.

According to the WHO report, in 2021, almost 190 million reproductive women and girls will be affected by endometriosis worldwide.The above data shows that there is massive potential in the market as the number of potential customers is in the millions and continues its grow as the population increases in developing countries; patients are still not aware of endometriosis and take the wrong drugs and treatment when there are any health problems.

Thus, different initiatives and awareness program are going on through social media, Online platforms, newspapers, and other means. Therefore, growing awareness about endometriosis can positively impact the market share.
The large number of women worldwide suffering from endometriosis led to increased demand for treatment.Due to its positive outcome, patients are suggesting the treatment to another patient, and this word of mouth are most impactful in term of awareness.

Hence, this factor can positively impact the market share.These increasing demands make the player work for significant technological Advancement in therapeutics and improving treatment.

Technological Advancement in segments helps the doctor to treat the patient with minimal surgical cuts on the body, less painful processes, and shorter recovery time. All these efforts make the method more in demand and market share.
Various community, government, and community initiatives are running to uplift women’s health.Australia has funded 58 million for improving endometriosis under the national action plan.

Janani Shishu Suraksha Yojana, National action plan, Women’s health alliance is an example of global initiatives.These policies led to increasing demand for endometriosis therapeutics in the market.

All the factors mentioned above are expected to drive the growth of the Endometriosis Therapeutics Market.
Off-Label Medication Practices are Hurdle in Growth
After so many awareness campaigns are running over the world, many people are still not reachable.Forget about the treatment.

They are unaware of endometriosis and take treatment for another problem. Apart from this, in poorer countries, therapy costs are costly that restrain the market growth.
Continuous R&D for Advance Drug Technology is Driving Growth
The evolution of methods and drugs due to technological advancement per market requirements is expected to create impressive growth in the Endometriosis Therapeutics Market. Market players are proposing novel transdermal drug delivery technologies such as topical applicators to overcome the side effects of oral contraceptives and improve efficiency as many women sufferings from endometriosis increase the demand for treatment.
In 2022, Myovant science Limited and Pfizer LLC.Is collaborate and continued to jointly commercialize MYFEMBREE.

This medicine is expected to help both companies combine their expertise to deliver the drug quickly and gain market size.
In 2022, Astellas Pharma Inc. announced the outcome of the drug, which is clinical trial version Phase 3, “SKYLIGHT 4“. It is a non-hormonal composite studied for treating sensible to severe vasomotor symptoms associated with menopause (VMS) which will encourage future regulatory organizing submissions.
Market Segmentation
The global endometriosis therapeutics market is segmented based on endometriosis type, diagnostic method, therapeutic method, distribution channel, and end user type.Based on endometriosis type, market is divided into superficial peritoneal lesion, endometrioma, deeply infiltrating endometriosis therapeutics.

Based on diagnostic method, market is divided into ultrasound, pelvic examination, laparoscopy, magnetic resonance imaging, and others.Based on treatment method, market is split into hormonal therapy, and pain management.

Based on drug category, market is divided into oral contraceptives, progestins, NSAIDs, GnRH analogues, and others.Based on diagnostics type, market is split into pure medical imaging v/s general laboratory use.

Based on distribution channel, market is divided into retail pharmacies, hospital pharmacies, online pharmacies. Based on end user, market is divided into hospitals & clinics, ambulatory care center, and others, by company.
Market Players
The Abbott Laboratories, Inc. ; AbbVie, Inc.; Bayer AG; Pfizer, Inc.; Ipsen SA; Evotec SE; Myovant Sciences Ltd.; Philogen S.p.A.; Astellas Pharma Inc.; Orphagen Pharmaceuticals, Inc. are the major market player operating in the Endometriosis Therapeutics Market.

Report Scope:

In this report, global Endometriosis Therapeutics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Endometriosis Therapeutics Market, by endometriosis type:
o Superficial Peritoneal Lesion
o Endometrioma
o Deeply Infiltrating Endometriosis Therapeutics
• Endometriosis Therapeutics Market, by diagnostic method:
o Ultrasound
o Pelvic Examination
o Laparoscopy
o Magnetic Resonance Imaging
o Others
• Endometriosis Therapeutics Market, by treatment method:
o Hormonal Therapy
o Pain Management
• Endometriosis Therapeutics, by drug category:
o Oral Contraceptives
o Progestins
o GnRH Analogues
o Others
• Endometriosis Therapeutics, by distribution channel:
o Retail Pharmacies
o Hospital Pharmacies
o Online Pharmacies
• Endometriosis Therapeutics Market, by end user type:
o Hospitals & Clinics
o Ambulatory Care Center
o Others
• Medical market, By Region:
o North America
United States
o Asia-Pacific
South Korea
o Europe & CIS
United Kingdom
o South America
o Middle East & Africa
South Africa
Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Endometriosis Therapeutics Market.

Available Customizations:

With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Alzheimer’s Disease Diagnostics & Therapeutics Market Research Report by Product, End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • $ 3949
  • January 2023
  • 226 pages

Alzheimer’s Disease Diagnostics & Therapeutics Market Research Report by Product (Diagnostics and Therapeutics), End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation ...

  • World
  • Therapy
  • Dementia
  • Industry analysis

Global Algae Fats Industry $ 4950 January 2023


Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on